HMGB1 and Miyoshi myopathy: Studies have shown that MM patients exhibited significantly elevated serum HMGB1 levels compared to asbestos-exposed (AE) individuals and healthy controls [21,22], with hyperacetylated HMGB1 demonstrating high sensitivity and specificity for distinguishing MM from AE individuals [23].